NAPL Napo Pharm.Regs

    RNS Number : 0801Y
  Napo Pharmaceuticals Inc
  01 July 2008
   

 For immediate release  1 July 2008


    Napo Pharmaceuticals Inc.
    ("Napo" or "the Company")

     Total Voting Rights and Share Capital

    In conformity with the Transparency Directive, Napo Pharmaceuticals, Inc. ("Napo") is required to notify the market of the following: 
      
    Napo has issued 507,614 common shares during this month and therefore Napo's current issued share capital (exclusive of shares held in
treasury) now consists of 54,206,383 common shares with a nominal value of USD $.0001 each, with voting rights. 

    Napo Pharmaceuticals, Inc. holds 125,614 common shares in Treasury. 

    Therefore, the total number of voting rights in Napo (exclusive of shares held in treasury) is 54,206,383. 

    The above figure of 54,206,383 common shares may be used by shareholders as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change to their interest in, Napo under the Financial Service Authority's
Disclosure and Transparency Rules. 

    Name of contact and telephone number for inquiries: 

    Charles Thompson,
    Napo Pharmaceuticals, Inc.
    Company Secretary: 
    650-616-1903 

    Napo Pharmaceuticals, Inc 
    Tel: 650-616-1900 
    1170 Veterans Boulevard, Suite 244 
    Fax: 650-873-8367 
    South San Francisco, CA 94080 
    USA 
    Delaware corporation number 3457397  

    Buchanan Communications
+ 44 (0)20 7466 5000
Tim Anderson, Mary-Jane Johnson, Catherine Breen 


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
TVRILFFRDDILIIT

Napo Pharm.Regs (LSE:NAPL)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024

Napo Pharm.Regs (LSE:NAPL)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024